Mark E. Tryniski's Insider Trades & SAST Disclosures
Mark E. Tryniski's most recent trade in Bancorp Inc. (The) was a trade of 5,000 Common Stock done at an average price of $50.4 . Disclosure was reported to the exchange on Oct. 29, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Mark E. Tryniski.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bancorp Inc. (The) | Mark E. Tryniski | Director | Purchase of securities on an exchange or from another person at price $ 50.36 per share. | 29 Oct 2024 | 5,000 | 10,105 (0%) | 0% | 50.4 | 251,803 | Common Stock |
| Bancorp Inc. (The) | Mark E. Tryniski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 5,105 | 5,105 (0%) | 0% | - | Common Stock | |
| Community Bank System, Inc. | E. Tryniski Mark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2024 | 1,395 | 1,395 | - | - | Phantom Stock (Deferred Stock Units) | |
| Community Bank System, Inc. | E. Mark Tryniski | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.11 per share. | 04 Jan 2024 | 11,706 | 29,395 (0%) | 0% | 52.1 | 610,000 | Common Stock |
| Community Bank System, Inc. | Mark E. Tryniski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2024 | 6,759 | 41,101 (0%) | 0% | 0 | Common Stock | |
| Community Bank System, Inc. | Mark E. Tryniski | Director, President & CEO | 15 Mar 2023 | 7,026 | 27,958 (0%) | 0% | 54.0 | 379,233 | Common Stock | |
| Community Bank System, Inc. | Mark E. Tryniski | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2023 | 16,885 | 16,885 | - | - | Stock Option | |
| Community Bank System, Inc. | Mark E. Tryniski | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2023 | 4,631 | 34,342 (0%) | 0% | 0 | Common Stock | |
| Community Bank System, Inc. | Mark E. Tryniski | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.05 per share. | 08 Mar 2023 | 1,704 | 29,711 (0%) | 0% | 61.0 | 104,029 | Common Stock |
| Conmed Corp. | Mark E. Tryniski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2022 | 812 | 0 | - | - | Rsus (restricted Stock Units) | |
| Conmed Corp. | Mark E. Tryniski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2022 | 812 | 9,108 (0%) | 0% | 0 | Common Stock | |
| Community Bank System, Inc. | Mark E. Tryniski | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2022 | 11,067 | 11,067 | - | - | Stock Option | |
| Community Bank System, Inc. | Mark E. Tryniski | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.94 per share. | 04 Mar 2022 | 1,643 | 28,662 (0%) | 0% | 72.9 | 119,840 | Common Stock |
| Conmed Corp. | Mark E. Tryniski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 51.90 per share. | 05 Nov 2021 | 4,892 | 13,188 (0%) | 0% | 51.9 | 253,895 | Common Stock |
| Conmed Corp. | Mark E. Tryniski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Nov 2021 | 4,892 | 0 | - | - | Options To Purchase Common Stock | |
| Conmed Corp. | Mark E. Tryniski | Director | Sale of securities on an exchange or to another person at price $ 156.51 per share. | 05 Nov 2021 | 4,792 | 8,396 (0%) | 0% | 156.5 | 749,986 | Common Stock |
| Conmed Corp. | Mark E. Tryniski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Nov 2021 | 3,399 | 0 | - | - | Options To Purchase Common Stock | |
| Conmed Corp. | Mark E. Tryniski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 69.03 per share. | 05 Nov 2021 | 3,399 | 11,695 (0%) | 0% | 69.0 | 234,633 | Common Stock |
| Conmed Corp. | Mark E. Tryniski | Director | Sale of securities on an exchange or to another person at price $ 156.44 per share. | 05 Nov 2021 | 2,899 | 8,796 (0%) | 0% | 156.4 | 453,517 | Common Stock |
| Conmed Corp. | Mark E. Tryniski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Nov 2021 | 2,886 | 0 | - | - | Options To Purchase Common Stock | |
| Conmed Corp. | Mark E. Tryniski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 79.94 per share. | 05 Nov 2021 | 2,886 | 11,182 (0%) | 0% | 79.9 | 230,707 | Common Stock |
| Conmed Corp. | Mark E. Tryniski | Director | Sale of securities on an exchange or to another person at price $ 156.44 per share. | 05 Nov 2021 | 2,386 | 8,796 (0%) | 0% | 156.4 | 373,256 | Common Stock |
| Conmed Corp. | Mark E. Tryniski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Nov 2021 | 1,843 | 0 | - | - | Options To Purchase Common Stock | |
| Conmed Corp. | Mark E. Tryniski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 73.94 per share. | 05 Nov 2021 | 1,843 | 10,139 (0%) | 0% | 73.9 | 136,271 | Common Stock |
| Conmed Corp. | Mark E. Tryniski | Director | Sale of securities on an exchange or to another person at price $ 156.48 per share. | 05 Nov 2021 | 1,743 | 8,396 (0%) | 0% | 156.5 | 272,750 | Common Stock |
| Conmed Corp. | Mark E. Tryniski | Director | Sale of securities on an exchange or to another person at price $ 156.95 per share. | 05 Nov 2021 | 500 | 8,296 (0%) | 0% | 157.0 | 78,475 | Common Stock |
| Conmed Corp. | Mark E. Tryniski | Director | Sale of securities on an exchange or to another person at price $ 157.06 per share. | 05 Nov 2021 | 500 | 8,296 (0%) | 0% | 157.1 | 78,531 | Common Stock |
| Conmed Corp. | Mark E. Tryniski | Director | Sale of securities on an exchange or to another person at price $ 157.05 per share. | 05 Nov 2021 | 100 | 8,296 (0%) | 0% | 157.1 | 15,705 | Common Stock |
| Conmed Corp. | Mark E. Tryniski | Director | Sale of securities on an exchange or to another person at price $ 157.11 per share. | 05 Nov 2021 | 100 | 8,296 (0%) | 0% | 157.1 | 15,711 | Common Stock |
| Conmed Corp. | Mark E. Tryniski | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Sep 2021 | 36,114 | 36,114 (0%) | 0% | 0 | Common Stock | |
| Conmed Corp. | Mark E. Tryniski | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Sep 2021 | 36,114 | 8,296 (0%) | 0% | 0 | Common Stock | |
| Conmed Corp. | Mark E. Tryniski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 1,521 | 0 | - | - | Rsus (restricted Stock Units) | |
| Conmed Corp. | Mark E. Tryniski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 1,521 | 44,410 (0%) | 0% | 0 | Common Stock | |
| Conmed Corp. | Mark E. Tryniski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 865 | 865 | - | - | Options To Purchase Common Stock | |
| Conmed Corp. | Mark E. Tryniski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 812 | 812 | - | - | Rsus (restricted Stock Units) | |
| Community Bank System, Inc. | Mark E. Tryniski | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2021 | 15,776 | 15,776 | - | - | Stock Option | |
| Community Bank System, Inc. | Mark E. Tryniski | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2021 | 3,650 | 57,569 (0%) | 0% | 0 | Common Stock | |
| Community Bank System, Inc. | Mark E. Tryniski | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.19 per share. | 05 Mar 2021 | 2,457 | 53,919 (0%) | 0% | 71.2 | 174,914 | Common Stock |
| Conmed Corp. | Mark E. Tryniski | Director | Sale of securities on an exchange or to another person at price $ 122.23 per share. | 19 Feb 2021 | 3,400 | 42,889 (0%) | 0% | 122.2 | 415,582 | Common Stock |
| Conmed Corp. | Mark E. Tryniski | Director | Sale of securities on an exchange or to another person at price $ 122.06 per share. | 19 Feb 2021 | 90 | 46,289 (0%) | 0% | 122.1 | 10,985 | Common Stock |
| Community Bank System, Inc. | Mark E. Tryniski | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2021 | 18,026 | 0 | - | - | Stock Option | |
| Community Bank System, Inc. | Mark E. Tryniski | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 37.77 per share. | 16 Feb 2021 | 18,026 | 68,939 (0%) | 0% | 37.8 | 680,842 | Common Stock |
| Community Bank System, Inc. | Mark E. Tryniski | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.32 per share. | 16 Feb 2021 | 12,563 | 56,376 (0%) | 0% | 70.3 | 883,430 | Common Stock |
| Conmed Corp. | Mark E. Tryniski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2021 | 7,195 | 0 | - | - | Options To Purchase Common Stock | |
| Conmed Corp. | Mark E. Tryniski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 41.06 per share. | 16 Feb 2021 | 7,195 | 53,574 (0%) | 0% | 41.1 | 295,427 | Common Stock |
| Conmed Corp. | Mark E. Tryniski | Director | Sale of securities on an exchange or to another person at price $ 121.31 per share. | 16 Feb 2021 | 2,545 | 46,379 (0%) | 0% | 121.3 | 308,734 | Common Stock |
| Conmed Corp. | Mark E. Tryniski | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 122.10 per share. | 16 Feb 2021 | 2,420 | 51,154 (0%) | 0% | 122.1 | 295,482 | Common Stock |
| Conmed Corp. | Mark E. Tryniski | Director | Sale of securities on an exchange or to another person at price $ 120.88 per share. | 16 Feb 2021 | 2,230 | 48,924 (0%) | 0% | 120.9 | 269,562 | Common Stock |
| Conmed Corp. | Mark E. Tryniski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.09 per share. | 16 Feb 2021 | 1,000 | 44,660 (0%) | 0% | 26.1 | 26,090 | Common Stock |
| Conmed Corp. | Mark E. Tryniski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.63 per share. | 16 Feb 2021 | 1,000 | 43,889 (0%) | 0% | 27.6 | 27,630 | Common Stock |
| Conmed Corp. | Mark E. Tryniski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2021 | 1,000 | 0 | - | - | Sars (Stock Appreciation Rights) | |
| Conmed Corp. | Mark E. Tryniski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2021 | 1,000 | 0 | - | - | Sars (Stock Appreciation Rights) | |
| Conmed Corp. | Mark E. Tryniski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2021 | 1,000 | 0 | - | - | Sars (Stock Appreciation Rights) | |
| Conmed Corp. | Mark E. Tryniski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2021 | 1,000 | 0 | - | - | Sars (Stock Appreciation Rights) | |
| Conmed Corp. | Mark E. Tryniski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2021 | 1,000 | 0 | - | - | Sars (Stock Appreciation Rights) | |
| Conmed Corp. | Mark E. Tryniski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 32.93 per share. | 16 Feb 2021 | 1,000 | 45,443 (0%) | 0% | 32.9 | 32,930 | Common Stock |
| Conmed Corp. | Mark E. Tryniski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 39.64 per share. | 16 Feb 2021 | 1,000 | 46,170 (0%) | 0% | 39.6 | 39,640 | Common Stock |
| Conmed Corp. | Mark E. Tryniski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 53.83 per share. | 16 Feb 2021 | 1,000 | 46,841 (0%) | 0% | 53.8 | 53,830 | Common Stock |
| Conmed Corp. | Mark E. Tryniski | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 120.69 per share. | 16 Feb 2021 | 462 | 46,379 (0%) | 0% | 120.7 | 55,759 | Common Stock |
| Conmed Corp. | Mark E. Tryniski | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 120.69 per share. | 16 Feb 2021 | 329 | 45,841 (0%) | 0% | 120.7 | 39,707 | Common Stock |
| Conmed Corp. | Mark E. Tryniski | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 120.69 per share. | 16 Feb 2021 | 273 | 45,170 (0%) | 0% | 120.7 | 32,948 | Common Stock |
| Conmed Corp. | Mark E. Tryniski | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 120.69 per share. | 16 Feb 2021 | 229 | 43,660 (0%) | 0% | 120.7 | 27,638 | Common Stock |
| Conmed Corp. | Mark E. Tryniski | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 120.69 per share. | 16 Feb 2021 | 217 | 44,443 (0%) | 0% | 120.7 | 26,190 | Common Stock |
| Conmed Corp. | Mark E. Tryniski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2020 | 1,876 | 0 | - | - | Rsus (restricted Stock Units) | |
| Conmed Corp. | Mark E. Tryniski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2020 | 1,876 | 42,889 (0%) | 0% | 0 | Common Stock | |
| Conmed Corp. | Mark E. Tryniski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2020 | 1,843 | 1,843 | - | - | Options To Purchase Common Stock | |
| Conmed Corp. | Mark E. Tryniski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2020 | 1,521 | 1,521 | - | - | Rsus (restricted Stock Units) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges